CN104436226A
|
|
Ultrasound diagnosis medical polymer material with targeting function
|
CN104436239A
|
|
Ferric oxide hollow ultrasound imaging microsphere material
|
CN104436209A
|
|
Adriamycin-containing macromolecule drug
|
CN104436223A
|
|
Medical high-molecular polymer microspheres containing magnetic particles
|
CN104436208A
|
|
Anti-tumor drug microcapsule preparation method
|
CN104434795A
|
|
Polymethacrylic acid type polymer drug micelles
|
CN104448331A
|
|
Anticancer macromolecule drug preparation method
|
CN104436237A
|
|
Medical macromolecule ultrasound diagnosis material
|
CN104436231A
|
|
Organic-inorganic composite ultrasonic imaging microsphere preparation method
|
CN104436244A
|
|
Targeting contrast agent preparation method
|
CN104436234A
|
|
Ferric oxide-containing medical contrast agent
|
CN104434793A
|
|
Cell microenvironment responsive drug micelle preparation method
|
CN104436246A
|
|
Novel medical magnetic nano-scale microsphere contrast agent
|
CN104436241A
|
|
Medical ultrasound diagnosis nanometer microsphere contrast agent system
|
CN104436224A
|
|
Magnetic ferric oxide composite medical contrast agent
|
CN104436240A
|
|
Method for preparing medical contrast agent by using polymethyl acrylate
|
CN104436238A
|
|
Medical-grade magnetic ultrasound targeting contrast agent microspheres
|
CN104434794A
|
|
Novel adriamycin tumor cell inhibiting micelle preparation method
|
CN104436233A
|
|
Medical contrast agent system containing magnetic material
|
CN104436242A
|
|
Composite nanometer microsphere system for medical diagnosis
|